May 23 |
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years
|
May 22 |
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?
|
May 22 |
Regeneron faces new biosimilar threats; an AI biotech lays off staff
|
May 20 |
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England Journal of Medicine
|
May 20 |
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
|
May 20 |
Regeneron Eylea generics approved by FDA
|
May 17 |
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
|
May 17 |
Regeneron wins temporary restraining order preventing Eylea generic launch
|
May 16 |
These 2 No-Brainer Growth Stocks Are Breaking New Ground
|
May 14 |
Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)
|